These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 17216337)
1. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Papas K; Kalbfleisch J; Mohon R Dig Dis Sci; 2007 Feb; 52(2):347-52. PubMed ID: 17216337 [TBL] [Abstract][Full Text] [Related]
2. A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis. Papas KA; Sontag MK; Pardee C; Sokol RJ; Sagel SD; Accurso FJ; Wagener JS J Cyst Fibros; 2008 Jan; 7(1):60-7. PubMed ID: 17569601 [TBL] [Abstract][Full Text] [Related]
3. Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis. Soltani-Frisk S; Gronowitz E; Andersson H; Strandvik B Acta Paediatr; 2001 Oct; 90(10):1112-5. PubMed ID: 11697419 [TBL] [Abstract][Full Text] [Related]
4. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals. Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354 [TBL] [Abstract][Full Text] [Related]
5. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Winklhofer-Roob BM; van't Hof MA; Shmerling DH Am J Clin Nutr; 1996 May; 63(5):722-8. PubMed ID: 8615355 [TBL] [Abstract][Full Text] [Related]
6. Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway. Dorlöchter L; Aksnes L; Fluge G Eur J Nutr; 2002 Aug; 41(4):148-52. PubMed ID: 12242582 [TBL] [Abstract][Full Text] [Related]
7. Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study. Johnson EJ; Vishwanathan R; Rasmussen HM; Lang JC Mol Vis; 2014; 20():1228-42. PubMed ID: 25352732 [TBL] [Abstract][Full Text] [Related]
8. Human vitamin E requirements assessed with the use of apples fortified with deuterium-labeled alpha-tocopheryl acetate. Bruno RS; Leonard SW; Park SI; Zhao Y; Traber MG Am J Clin Nutr; 2006 Feb; 83(2):299-304. PubMed ID: 16469987 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease. Cuerq C; Henin E; Restier L; Blond E; Drai J; Marçais C; Di Filippo M; Laveille C; Michalski MC; Poinsot P; Caussy C; Sassolas A; Moulin P; Reboul E; Charriere S; Levy E; Lachaux A; Peretti N J Lipid Res; 2018 Sep; 59(9):1640-1648. PubMed ID: 30021760 [TBL] [Abstract][Full Text] [Related]
10. The occurrence and effects of human vitamin E deficiency. A study in patients with cystic fibrosis. Farrell PM; Bieri JG; Fratantoni JF; Wood RE; di Sant'Agnese PA J Clin Invest; 1977 Jul; 60(1):233-41. PubMed ID: 874086 [TBL] [Abstract][Full Text] [Related]
11. Vitamin E and vitamin E acetate absorption from self-assembly systems under pancreas insufficiency conditions. Nagy K; Lobo B; Courtet-Compondu MC; Braga-Lagache S; Ramos L; Puig-Divi V; Azpiroz F; Malagelada JR; Beaumont M; Moulin J; Acquistapace S; Sagalowicz L; Kussmann M; Santos J; Holst B; Williamson G Chimia (Aarau); 2014; 68(3):129-34. PubMed ID: 24801842 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat. Teng XW; Davies NM; Fukuda C; Good RL; Fariss MW Biopharm Drug Dispos; 2005 Jul; 26(5):195-203. PubMed ID: 15900617 [TBL] [Abstract][Full Text] [Related]
13. Ratio of bioavailability of RRR-/all-rac-alpha-tocopherol. Machlin LJ Am J Clin Nutr; 1995 May; 61(5):1169-70. PubMed ID: 7733046 [No Abstract] [Full Text] [Related]
14. [Effect of nutritional status on absorption kinetics of vitamin E in mucoviscidosis]. Skopnik H; Karl M; Kusenbach G; Bergt U; Geron M; Heimann G Klin Padiatr; 1990; 202(1):43-9. PubMed ID: 2314001 [TBL] [Abstract][Full Text] [Related]
15. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Sitrin MD; Lieberman F; Jensen WE; Noronha A; Milburn C; Addington W Ann Intern Med; 1987 Jul; 107(1):51-4. PubMed ID: 3592448 [TBL] [Abstract][Full Text] [Related]
16. Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. Kuo F; Subramanian B; Kotyla T; Wilson TA; Yoganathan S; Nicolosi RJ Int J Pharm; 2008 Nov; 363(1-2):206-13. PubMed ID: 18718513 [TBL] [Abstract][Full Text] [Related]
17. Improvement of the bioavailability of colchicine in rats by co-administration of D-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid. Bittner B; Guenzi A; Fullhardt P; Zuercher G; González RC; Mountfield RJ Arzneimittelforschung; 2002; 52(9):684-8. PubMed ID: 12404883 [TBL] [Abstract][Full Text] [Related]
18. Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol? Back EI; Frindt C; Oćenásková E; Nohr D; Stern M; Biesalski HK Eur J Nutr; 2006 Feb; 45(1):1-6. PubMed ID: 15765200 [TBL] [Abstract][Full Text] [Related]
19. Physiological factors influencing vitamin E biokinetics. Lodge JK; Hall WL; Jeanes YM; Proteggente AR Ann N Y Acad Sci; 2004 Dec; 1031():60-73. PubMed ID: 15753134 [TBL] [Abstract][Full Text] [Related]
20. Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E. Radosavac D; Graf P; Polidori MC; Sies H; Stahl W Eur J Nutr; 2002 Jun; 41(3):119-24. PubMed ID: 12111049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]